The online version of this article (doi:10.1186/1471-2253-14-18) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
HCP, MK, JB, JR and JBD made substantial contributions to the conception and design of the study. HCP and MK made the data analysis. HCP drafted the manuscript. HCP, MK, JB, JR and JBD made critical revisions of the manuscript. All authors read and approved the final version of the manuscript.
Non-steroid anti-inflammatory drugs (NSAIDs) have been proposed as part of a multimodal postoperative analgesia in patients operated for colorectal cancer. However, whether these drugs are prescribed and taken by the patients have not been evaluated. The aim of this study was to quantify the postoperative use of NSAIDs in these patients.
Data from patients operated for colorectal cancer between January 1, 2006 and December 31, 2009 were collected from the Danish Colorectal Cancer Group’s (DCCG) prospective database. From the electronically registered medical records, data for the use of the two NSAIDs diclofenac and ibuprofen were recorded. The data from six colorectal departments in eastern Denmark were compared.
Of the 2,754 patients analyzed overall, 40.6% received NSAIDs as part of their analgesic treatment. The percentage of the patients receiving NSAIDs, receiving a pre-defined dosage as a minimum and receiving NSAIDs as p.r.n. medication, and the type of NSAID were significantly different both between department and within departments. The median dose of ibuprofen and diclofenac were 1200 mg (400–2,400 mg) and 100 mg (50–200 mg), respectively.
The large variation between and within the departments points to an inconsistency in the use of multimodal post-operative pain treatments. This may be a result of insufficient evidence on procedure specific pain treatments and possibly a lack of compliance to existing guidelines. High-quality large-scale studies are warranted to form the basis for guidelines for postoperative analgesic treatment.
Fletcher D, Fermanian C, Mardaye A, Aegerter P, Pain and Regional Anesthesia Committee of the French Anesthesia and Intensive Care Society: A patient-based national survey on postoperative pain management in France reveals significant achievements and persistent challenges. Pain. 2008, 137 (2): 441-451. 10.1016/j.pain.2008.02.026. CrossRefPubMed
Mathiesen O, Thomsen BA, Kitter B, Dahl JB, Kehlet H: Need for improved treatment of postoperative pain. Dan Med J. 2012, 59 (4): A4401- PubMed
Nationwide database for cancer of the colon and rectum - yearly report. . [ http://dccg.dk/03_Publikation/02_arsraport_pdf/aarsrapport_2010.pdf]
Gogenur I, Ingeholm P, Iversen LH: [Danish colorectal cancer database]. Ugeskr Laeger. 2012, 174 (42): 2525- PubMed
PROSPECT working group. . [ http://www.postoppain.org/]
Holst Andersen LP, Werner MU, Rosenberg J, Gogenur I: Procedure specific pain management in relation to laparoscopic colonic surgery. Ugeskr Laeger. 2013, 175 (11): 721-725. PubMed
Klein M, Holst Andersen LP, Gogenur I, Rosenberg J: COX-2 selective NSAIDs should not be used after colorectal surgery. Colorectal Dis. 2013, 15 (9): 1186- PubMed
- Variation in postoperative non-steroidal anti-inflammatory analgesic use after colorectal surgery: a database analysis
Jørgen B Dahl
The Scandinavian Postoperative Pain Alliance (SCAPALLI)
- BioMed Central
Neu im Fachgebiet AINS
Meistgelesene Bücher aus dem Fachgebiet AINS
Mail Icon II